Pharma emergency...galafold (MIGALASTAT) 123MG caps
Ended Awarded Last action
- Contract number
- 36C24925F0058
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89 Part of Amicus Therapeutics, Inc.
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $63,268
Award facts
- Contract value 100% obligated
- $63,268.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the delivery of Galafold (migalastat) 123mg capsules, an enzyme replacement therapy for the treatment of Fabry disease. The contract, valued at $63,268.41, was awarded by the U.S. Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a subsidiary of the biopharmaceutical company Amicus Therapeutics, Inc.
The contract is a firm fixed-price delivery order issued under Amicus Therapeutics US, LLC's Federal Supply Schedule (FSS) contract with the VA, which has a ceiling value of $13,024,630 and a period of performance through August 31, 2029. This FSS contract, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, allows the VA to efficiently procure a range of pharmaceutical products to support its mission of providing specialized healthcare services and medications to veterans. The contract does not have a set-aside designation.
The award represents the continued partnership between Amicus Therapeutics US, LLC and the VA's Veterans Health Administration, as the company consistently fulfills emergency pharmacy orders and regular supply requests for Galafold to various Veterans Integrated Service Networks (VISNs) across the country, ensuring continuous access to this critical medication for veterans with Fabry disease.
Quick answers
Who was awarded contract 36C24925F0058?
36C24925F0058 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 9 (Veterans Health Administration) on October 28, 2024.
How much is contract 36C24925F0058 worth?
The government has obligated $63,268 on 36C24925F0058.
Is contract 36C24925F0058 an order under another contract?
Yes. 36C24925F0058 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24925F0058 competed?
The extent of competition for 36C24925F0058 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award